Metropolis Healthcare awards Scholarships to 50 Medical Students

S Singh
S Singh
· 3 min read
Metropolis
Ameera Shah, Founder and Managing Director, Metropolis Healthcare Ltd addressing the gathering at the scholarship awards ceremony

Metropolis Healthcare Ltd., a global chain of pathology labs and diagnostic centers, today awarded 50 Medical Students under their Medical Talen Outreach Programme titled “MEDENGAGE”. The initiative has been launched by Metropolis Healthcare to nurture and nourish medical talent in the nation today.

While addressing at the award ceremony, Dr Sushil Shah, Founder & Chairman, Metropolis Healthcare, said, “In my personal experience during my student years, I have observed that many bright students couldn’t pursue medical science due to financial difficulties. And I feel industry deprived these bright students from becoming specialist doctors. Students who don’t have money but want to do something constructive, needs funding for research or thesis. Also students who are pursuing undergraduate or graduation programs in medical science needs to be exposed to modern technology as the current syllabus I feel is outdated. We believe through MEDENGAGE we are able to support the aspiring medical students to some extent which will benefit them financially through our scholarship program. We got an overwhelming response of over 4500 students from 500 medical institutions not just from India, but also from other international countries like Zambia, Ghana, China, Russia and Japan. We have shortlisted 50 best students and are awarding them scholarships and awards to prosper further.”

Speaking about MEDENGAGE, Ameera Shah, Founder & Managing Director, said, “Healthcare sector has evolved in the last two decades. Patients today are more evolved and more aware of their conditions, available treatment and management options and are making intelligent decisions. Additionally, insurance penetration has increased dramatically today to about 50-60 percent in hospital income. Over the next decade it is likely to grow 60-80 percent. Initiative like Ayushman Bharat has given opportunity for better healthcare to the rural sector. Ayushman Bharat is expected to add 300-400 million patients exposed to healthcare. Technology innovations like Artificial Intelligence, Data Analytics are changing the dynamics of medical science. With the help of technology, a common pool of data can be created which can be accessed by various stake holders in healthcare ecosystem. Lastly, any student and the entire medical fraternity need to keep patient as the utmost priority while keeping in mind the changing dynamics in the sector.”

MEDENGAGE is an effort by Metropolis to engage and partner with medical students who essentially form the future way-forward supporting the world class laboratory assistance to raise the bar of academic research in the country. This is a part of the company’s social initiatives to bring changes and improve the healthcare research and academic landscape in India.

Read Next

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management
Corporate
January 27, 2026

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management

Company to launch product after the expiry of semaglutide patent in India Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct to […]
Article by: IMT News Desk
Lupin receives highest ESG rating from CDP for climate change and water security
Corporate
January 27, 2026

Lupin receives highest ESG rating from CDP for climate change and water security

The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency at the highest level Lupin has received the highest ‘A’ leadership rating from Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency […]
Article by: IMT News Desk
AstraZeneca Pharma India receives CDSCO approval for breast cancer drug
Corporate
December 19, 2025

AstraZeneca Pharma India receives CDSCO approval for breast cancer drug

Dato-DXd is a specifically engineered antibody drug conjugate that targets TROP2, a protein frequently overexpressed in breast cancer AstraZeneca Pharma India announced that the Central Drugs Standard Control Organisation (CDSCO) has granted regulatory approval to import, sell, and distribute Datopotamab Deruxtecan (Dato-DXd) in India. The approval reflects AstraZeneca’s focus on bringing to life-changing medicines at […]
Article by: IMT News Desk
Novo Nordisk launches Ozempic in India
Corporate
December 12, 2025

Novo Nordisk launches Ozempic in India

Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living with uncontrolled type 2 diabetes mellitus Novo Nordisk announced the launch of Ozempic (injectable semaglutide) in India. Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living […]
Article by: IMT News Desk